Evaluation of antitumor activity of a TGF-beta receptor I inhibitor (SD-208) on human colon adenocarcinoma

BACKGROUND: Transforming growth factor-β (TGF-β) pathway is involved in primary tumor progression and in promoting metastasis in a considerable proportion of human cancers such as colorectal cancer (CRC). Therefore, blockage of TGF-β pathway signaling via an inhibitor could be a valuable tool in CRC...

Descripción completa

Detalles Bibliográficos
Autores principales: Akbari, Abolfazl, Amanpour, Saeid, Muhammadnejad, Samad, Ghahremani, Mohammad Hossein, Ghaffari, Seyed Hamidollah, Dehpour, Ahmad Reza, Mobini, Gholam Reza, Shidfar, Fatemeh, Abastabar, Mahdi, Khoshzaban, Ahad, Faghihloo, Ebrahim, Karimi, Abbas, Heidari, Mansour
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077684/
https://www.ncbi.nlm.nih.gov/pubmed/24902843
http://dx.doi.org/10.1186/2008-2231-22-47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077684/
https://www.ncbi.nlm.nih.gov/pubmed/24902843
http://dx.doi.org/10.1186/2008-2231-22-47

Ejemplares similares